Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicky Longley

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The Lancet. Rheumatology|February 1, 2021
Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemmaPuja Mehta, Emilie Sanchez, Elena Moraitis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2011
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Ann Percival, Sean Bauman, et al.
The Journal of Infection|November 15, 2011
Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitisConrad K Muzoora, Taseera Kabanda, Giuseppina Ortu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2015
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyNicky Longley, Joseph Nicholas Jarvis, Graeme Meintjes, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 28, 2012
Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementationJoseph N Jarvis, Nelesh Govender, Tom Chiller, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 27, 2011
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?Joseph N Jarvis, Thomas S Harrison, Nelesh Govender, et al.
Elife|February 9, 2023
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agendaEmily Martyn, Sarah Eisen, Nicky Longley, et al.
Trials|March 9, 2021
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trialLi-An K Brown, Nick Freemantle, Judy Breuer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2009
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsTihana Bicanic, Conrad Muzoora, Annemarie E Brouwer, et al.
Open Forum Infectious Diseases|December 3, 2020
Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South AfricansShichina Kannambath, Joseph N Jarvis, Rachel M Wake, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The Lancet. Rheumatology|February 1, 2021
Influenza vaccination and interruption of methotrexate in adult patients in the COVID-19 era: an ongoing dilemmaPuja Mehta, Emilie Sanchez, Elena Moraitis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2011
Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitisJoseph N Jarvis, Ann Percival, Sean Bauman, et al.
The Journal of Infection|November 15, 2011
Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitisConrad K Muzoora, Taseera Kabanda, Giuseppina Ortu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2015
Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyNicky Longley, Joseph Nicholas Jarvis, Graeme Meintjes, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 28, 2012
Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementationJoseph N Jarvis, Nelesh Govender, Tom Chiller, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 27, 2011
Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa?Joseph N Jarvis, Thomas S Harrison, Nelesh Govender, et al.
Elife|February 9, 2023
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agendaEmily Martyn, Sarah Eisen, Nicky Longley, et al.
Trials|March 9, 2021
Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trialLi-An K Brown, Nick Freemantle, Judy Breuer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2009
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patientsTihana Bicanic, Conrad Muzoora, Annemarie E Brouwer, et al.
Open Forum Infectious Diseases|December 3, 2020
Genome-Wide Association Study Identifies Novel Colony Stimulating Factor 1 Locus Conferring Susceptibility to Cryptococcosis in Human Immunodeficiency Virus-Infected South AfricansShichina Kannambath, Joseph N Jarvis, Rachel M Wake, et al.
Pageof 4